Poole Jonathan
SEC insider (Form 3/4/5 filer). CIK 0001604689. Director at ACADIA PHARMACEUTICALS INC (ACAD). 7 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in SAN DIEGO, CA.
Companies Poole Jonathan has filed insider reports for
- ACADIA PHARMACEUTICALS INC (ACAD): Director
Poole Jonathan
CIK: 0001604689
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACADIA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect2K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectDirector Stock Options (Right to Buy)
16K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
9.3K shares- - Mar 3, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectDirector Stock Options (Right to Buy)
7.5K shares- - Mar 3, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectDirector Stock Options (Right to Buy)
3.6K shares- - Mar 3, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
4.2K shares- - Mar 3, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 2,010 | - | $0 | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Director Stock Options (Right to Buy) | 16,004 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 9,311 | - | - | Direct |
| Mar 3, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Director Stock Options (Right to Buy) | 7,482 | - | - | Direct |
| Mar 3, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Director Stock Options (Right to Buy) | 3,565 | - | - | Direct |
| Mar 3, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 4,218 | - | - | Direct |
| Mar 3, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 2,010 | - | - | Direct |
1-7 of 7 transactions